CMO
TMO icon

Covenant Multifamily Offices’s Thermo Fisher Scientific TMO Stock Holding History

Covenant Multifamily Offices’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$241K Hold
422
– – 0.04% 208
2021
Q2 		$213K Buy
+422
New +$199K 0.04% 215

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Covenant Multifamily Offices's TMO Position: Q3 2021 in Review

Covenant Multifamily Offices held its Thermo Fisher Scientific (TMO) position steady in Q3 2021 at 422 shares worth $241K. The position accounts for 0.04% of the portfolio, ranked #208.

Covenant Multifamily Offices first reported a position in TMO in Q2 2021 and has held it in 2 quarters since. 2,129 funds tracked by Wall St. Rank hold TMO as of Q3 2021.

  • Covenant Multifamily Offices held 422 shares of Thermo Fisher Scientific worth $241K as of Q3 2021.
  • Covenant Multifamily Offices left its Thermo Fisher Scientific share count unchanged in Q3 2021.
  • Thermo Fisher Scientific made up 0.04% of Covenant Multifamily Offices's portfolio in Q3 2021, its #208 holding.
  • Covenant Multifamily Offices first reported a position in Thermo Fisher Scientific in Q2 2021 and has held it in 2 quarters since.
  • 2,129 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2021.

Based on Covenant Multifamily Offices's 13F filing for Q3 2021, filed 21 Oct 2021.